Ultrasound-guided treatment for shoulder pain
Ultrasound-Guided Hydrodilatation With Triamcinolone Acetonide for Adhesive Capsulitis:The Effect of the Rotator Cuff Interval With Posterior Glenohumeral Recess Approaches on the Improvement of Joint Motion and Pain
This study tests whether a new ultrasound-guided treatment for shoulder pain works better when done in two areas instead of just one for people with adhesive capsulitis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | General Hospital of Ningxia Medical University Academic / other |
| Locations | 1 site (Yinchuan, Ningxia) |
| Trial ID | NCT06553716 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of ultrasound-guided hydrodilatation techniques for treating adhesive capsulitis, a condition causing shoulder pain and stiffness. It specifically evaluates the combination of hydrodilatation through the rotator cuff interval and posterior glenohumeral recess against hydrodilatation through the rotator cuff interval alone. Patients will undergo imaging assessments to confirm their diagnosis before participating in the treatment. The goal is to determine which approach provides better relief from symptoms and improves shoulder mobility.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a clinical diagnosis of adhesive capsulitis and limited shoulder range of motion lasting more than one month.
Not a fit: Patients with secondary frozen shoulder conditions or those who have had previous shoulder surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve shoulder function for patients with adhesive capsulitis.
How similar studies have performed: Other studies have shown promising results with similar ultrasound-guided hydrodilatation techniques, suggesting potential efficacy in treating adhesive capsulitis.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years old, clinical diagnosis of periarthritis of shoulder; 2. symptom duration \> 1 month, shoulder ROM limitation in at least two directions, defined as abduction \< 80°, flexion \< 130°, and rotation \< 30°; 3. Before enrollment, the patients received plain radiographs, ultrasound images, and magnetic resonance imaging to rule out the cause of secondary shoulder capsitis. Exclusion Criteria: 1. Secondary frozen shoulder, such as rotator cuff tear, calcifying tendinitis, osteoarthritis, infection, tuberculosis infection, rheumatic disease, shoulder impingement syndrome; 2. Previous history of shoulder joint surgery; 3. Involved cervical nervous system symptoms or abnormal nervous system; 4. corticosteroid injection in the affected shoulder within 3 months; 5. Mental illness; 6. Patients with contraindications to cortisol-hormone use.
Where this trial is running
Yinchuan, Ningxia
- General hospital of Ningxia medical university — Yinchuan, Ningxia, China (Recruiting)
Study contacts
- Study coordinator: Xinli Ni, MD
- Email: xinlini6@nyfy.com.cn
- Phone: 13909586966
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.